Umbilical cord mesenchymal stromal cells attenuate experimental lupus and modulate CD3ζ expression in CD4⁺ T cells
CD3ζ, encoded by SLE susceptibility gene CD247, is essential for TCR signaling and T cell responses. While genetically linked to systemic lupus erythematosus (SLE), its role in SLE progression remains unclear. Flow cytometry quantified CD4⁺CD3ζdim T-cell frequencies and IFN-γ production in patients with SLE and lupus mouse models. A genetic model with reduced CD3ζ expression in the CD4 lineage was evaluated in resiquimod- and pristane-induced lupus. Changes associated with mesenchymal stromal cell transplantation (MSCT) were assessed in lupus mice. Co-immunoprecipitation and protein degradation assays investigated CD3ζ regulation and the effects of MSC-derived extracellular vesicles (MSC-EVs) in vitro. CD4⁺CD3ζdim T-cell frequencies were increased in patients with SLE and lupus mice. These cells exhibited greater IFN-γ production than CD4⁺CD3ζbright T cells. Mice with CD4-lineage CD3ζ reduction showed more severe induced lupus manifestations, including increased B-cell and plasmablast responses and exacerbated proteinuria. MSCT-treated mice showed improved disease manifestations, accompanied by lower CD4⁺CD3ζdim T-cell frequencies and reduced IFN-γ production. In vitro, TRIM21 associated with CD3ζ and was implicated in the negative regulation of its protein abundance. TRIM21 expression was inversely associated with CD3ζ expression in lupus and MSC-EVs increased CD3ζ protein expression and modulated TRIM21 in vitro. CD4⁺CD3ζdim T cells are more frequent in patients with SLE and lupus mice and exhibit greater IFN-γ production than CD4⁺CD3ζbright T cells. Mice with genetically reduced CD3ζ expression in the CD4 lineage exhibit aggravated disease manifestations following resiquimod or pristane induction. MSCT-treated mice show improved lupus manifestations and reduced TRIM21 expression. In vitro findings support the involvement of TRIM21 in regulating CD3ζ abundance and show that MSC-EVs increase CD3ζ protein expression. CD4⁺CD3ζdim T-cell frequencies are increased in patients with SLE and lupus-prone mice. CD4⁺ T-cell-specific CD3ζ knockdown aggravates resiquimod- and pristane-induced lupus. CD4⁺CD3ζdim T cells produce more IFN-γ than CD4⁺CD3ζbright T cells. MSCT ameliorates murine lupus, accompanied by lower CD4⁺CD3ζdim T-cell frequencies and reduced IFN-γ production. MSC-EVs increase CD3ζ protein expression in vitro, with TRIM21 implicated in this regulation.
Authors
- Hsiang‐i Tsai (ORCID: https://orcid.org/0000-0002-4233-1428)
- Yingyi Wu (ORCID: https://orcid.org/0000-0003-3966-785X)
- Huimin Zhu
- Dandan Wang (ORCID: https://orcid.org/0000-0002-9370-0668)
- Shanshan Liu
- Xinyu Li
- Yafeng Wang
- Lingyun Sun
- Yang Deng
Institutions
- Jiangsu University (CN)
- China Pharmaceutical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
- Zhejiang University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s13287-026-05402-w
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China